Health
BIOCAD will produce the COVID-19 vaccine developed by Gamalei Institute – EurekAlert
On September 23, 2020, the biotechnology company BIOCAD signed an agreement on the industrial production of the COVID-19 vaccine with the Research Center for Epidemiology and Microbiology of the Ministry of Health of Russia named after V. Gamaleya. BIOCAD bec…
Clinical trials of the vaccine are currently underway. The «Sputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a new adenovirus. This is done in order to exclude the presence of neutralizing antibodies against the vaccine in humans and thus enhance the reliability of repeated injection. The article on the «Sputnik V» vaccine was published b…
-
Noosa News16 hours agoForum responds to urgent homelessness issues in Nambour
-
Noosa News15 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General15 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers
-
Business14 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?